* Cellectis (CLLS [https://seekingalpha.com/symbol/CLLS]) is scheduled to announce Q3 earnings results on Thursday, November 13th, after market close.
* The consensus EPS Estimate is -$0.11 [https://seekingalpha.com/symbol/CLLS/earnings/estimates] and the consensus Revenue Estimate is $16.07M (-11.0% Y/Y).
* Over the last 1 year, CLLS has beaten EPS estimates [https://seekingalpha.com/symbol/CLLS/earnings/eps-surprise-summary] 50% of the time and has beaten revenue estimates 25% of the time.
* Over the last 3 months, EPS estimates have seen 1 upward revision [https://seekingalpha.com/symbol/CLLS/earnings/revisions] and 0 downward. Revenue estimates have seen 1 upward revision and 2 downward.
MORE ON CELLECTIS
* Allogene licensor Cellectis faces patent lawsuit in the U.S. [https://seekingalpha.com/news/4503953-allogene-licensor-cellectis-faces-patent-case]
* Seeking Alpha’s Quant Rating on Cellectis [https://seekingalpha.com/symbol/CLLS/ratings/quant-ratings]
* Historical earnings data for Cellectis [https://seekingalpha.com/symbol/CLLS/earnings]
* Financial information for Cellectis [https://seekingalpha.com/symbol/CLLS/income-statement]
Cellectis Q3 2025 Earnings Preview
Published 2 hours ago
Nov 12, 2025 at 4:12 PM
Positive
Auto